Zobrazeno 1 - 10
of 14
pro vyhledávání: '"K. E. Wende"'
Publikováno v:
American Journal of Physical Medicine & Rehabilitation. 82:427-436
OBJECTIVE This study is a secondary analysis of results from the Multiple Sclerosis Collaborative Research Group multicenter trial. We investigated the effect of interferon beta-1a on disability in patients with relapsing-remitting multiple sclerosis
Autor:
Carleton C. Stewart, K. E. Wende, Kathleen M. Hovey, David S. Bell, Carolyn L. Warner, Diane Cookfair
Publikováno v:
Cytometry. :26-33
Background There is a growing body of evidence supporting the theory that problems with immune function play an important role in chronic fatigue syndrome (CFS). Methods We studied 90 CFS cases and 50 healthy controls from two different areas of upst
Autor:
Lawrence Jacobs, K. E. Wende, Muriel D. Lezak, Anna L. Davidson, J. S. Fischer, Dennis Bourdette, Jack H. Simon, Mark Schacter, John R. Richert, Robert M. Herndon, Jordan Grafman, David W. Shucard, Katherine Kawczak Perkins, Carl V. Granger, Donald E. Goodkin, Kathleen M. Hovey, Diane Cookfair, Roger L. Priore, Richard A. Rudick, Mariska Kooijmans-Coutinho, Danielle Barilla-Clark, Andres M. Salazar
Publikováno v:
Annals of Neurology. 48:885-892
Cognitive dysfunction is common in multiple sclerosis (MS), yet few studies have examined effects of treatment on neuropsychological (NP) performance. To evaluate the effects of interferon β-1a (IFNβ-1a, 30 μg administered intramuscularly once wee
Autor:
N S Lava, Aaron E. Miller, Brian Apatoff, K. E. Wende, Andrew D. Goodman, Lawrence Jacobs, L Krupp, Malcolm Gottesman, A B Perel, D H Snyder, C Mihai, Carol M. Brownscheidle, Carl V. Granger, P K Coyle, C R Smith, Steven J. Greenberg, Joseph Herbert
Publikováno v:
Multiple Sclerosis. 5:369-376
We have obtained a current profile of multiple sclerosis (MS) in New York State through a centralized patient registry and standardized data collection instrument associated with the New York State Multiple Sclerosis Consortium of 12 MS centers locat
Autor:
N. A. Simonian, Kathy O'Reilly, J. S. Fischer, Michele K. Mass, Jonathan Braiman, Lawrence Jacobs, K. E. Wende, Frederick E. Munchsauer, Barbara J. Scherokman, Carol M. Brownscheidle, Carl V. Granger, Robert M. Herndon, David S. Dougherty, David M. Bartoszak, Donald E. Goodkin, John R. Richert, Bianca Weinstock-Guttman, Richard A. Rudick, Roger L. Priore, Andres M. Salazar, Diane Cookfair, Stanley L. Cohan, Ruth H. Whitham, Dennis Bourdette, Michael E. Coats, R. P. Kinkel, Richard M. Ransohoff, Patrick M. Pullicino, Jack H. Simon
Publikováno v:
Journal of Neuroimmunology. 93:8-14
Background and objective : This report provides results of CSF analyses done in a subset of relapsing remitting MS patients participating in a placebo-controlled, double-blind, phase III clinical trial of IFNβ-Studies supported by the National Multi
Autor:
Frederick Munschauer, J. S. Fischer, Michele Mass, Diane Cookfair, John R. Richert, Ruth H. Whitham, Dennis Bourdette, Michael E. Coats, M. Campion, Barbara J. Scherokman, Carol M. Brownscheidle, Carl V. Granger, R. P. Kinkel, Donald E. Goodkin, Robert M. Herndon, Roger L. Priore, Lawrence Jacobs, Bianca Weinstock-Guttman, John J. Alam, RA Rudick, David S. Dougherty, Stanley Cohan, Andres M. Salazar, K. E. Wende, David M. Bartoszak, Patrick M. Pullicino, Jack H. Simon, J. Braiman
Publikováno v:
Multiple Sclerosis. 4:480-486
We compared the ability of the Kurtzke Expanded Disability Status Scale (EDSS) and a composite outcome of non-physician-based measures of time to ambulate 25 feet (TA) and manual dexterity (the Box and Block Test [BBT], and 9-Hole Peg Test [9HPT]) to
Autor:
Ann Scherzinger, Bianca Weinstock-Guttman, Frederick Munschauer, Carol M. Brownscheidle, Carl V. Granger, Roger L. Priore, Richard A. Rudick, John J. Alam, Patrick M. Pullicino, Lawrence Jacobs, Jack H. Simon, Robert M. Herndon, Michele Mass, Andres M. Salazar, Jeanelle Sheeder, K. E. Wende, N. A. Simonian, Stanley Cohan, Michelle Lajaunie, David S. Dougherty, Jonathan Braiman, Diane Cookfair, J. S. Fischer, Ruth H. Whitham, Michael E. Coats, Mary Joel Meyer, Donald E. Goodkin, David M. Bartoszak, Kim Choi, Dennis Bourdette, Barbara J. Scherokman, John R. Richert, R. P. Kinkel, Anna L. Martens-Davidson, M. Campion
Publikováno v:
Annals of Neurology. 43:79-87
The Multiple Sclerosis Collaborative Research Group trial was a double-blind, randomized, multicenter, phase III, placebo-controlled study of interferon beta-1a (IFNbeta-1a; AVONEX) in relapsing forms of multiple sclerosis. Initial magnetic resonance
Autor:
S R, Schwid, A D, Goodman, B R, Apatoff, P K, Coyle, L D, Jacobs, L B, Krupp, A E, Miller, K E, Wende, C M, Brownscheidle, New York State Multiple Sclero
Publikováno v:
Neurology. 55(12)
Article abstract The authors used data collected prospectively during a multicenter trial in 133 patients with secondary progressive MS to assess the relative sensitivity of quantitative functional tests and traditional measures, including the Expand
Autor:
J S, Fischer, R L, Priore, L D, Jacobs, D L, Cookfair, R A, Rudick, R M, Herndon, J R, Richert, A M, Salazar, D E, Goodkin, C V, Granger, J H, Simon, J H, Grafman, M D, Lezak, K M, O'Reilly Hovey, K K, Perkins, D, Barilla-Clark, M, Schacter, D W, Shucard, A L, Davidson, K E, Wende, D N, Bourdette, M F, Kooijmans-Coutinho
Publikováno v:
Annals of neurology. 48(6)
Cognitive dysfunction is common in multiple sclerosis (MS), yet few studies have examined effects of treatment on neuropsychological (NP) performance. To evaluate the effects of interferon beta-1a (IFNbeta-1a, 30 microg administered intramuscularly o
Autor:
K E, Wende
Publikováno v:
Rehab management. 12(2)